Bruker (FRA:BKD) Tariff Resilience Score: 7/10 (As of Jul. 12, 2026)


FRA:BKD Bruker Corp FRA:BKD
85 GF Score
Price €52.41
GF Value €54.76
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Bruker Tariff Resilience Score?

Bruker FRA:BKD -0.51% 85 Tariff Resilience Score is 7 as of Jul. 12, 2026. GuruFocus rates FRA:BKD with a GF Score™ of 85/100 and a GF Value™ of €54.76 (Fairly Valued). The stock has 10 warning signs investors should review. Among 835 Medical Devices & Instruments companies, Bruker ranks better than 98.08% on this metric.

Bruker has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Bruker has Bruker Corp faces some tariff risks due to its global supply chain and international sales. However, its strong market position and ability to pass costs to customers provide resilience. The company has historically managed tariff impacts through strategic supplier adjustments.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Bruker might have Highly Resilient.

Bruker  (FRA:BKD) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Bruker Tariff Resilience Score Related Terms

FRA:BKD vs GKOS, BIO, PODD: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Bruker's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bruker Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Bruker's Tariff Resilience Score falls into.


FRA:BKD
85GF Score
Bruker Corp FRA:BKD
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Bruker (FRA:BKD) has a Tariff Resilience Score of 7 as of Jul. 12, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Bruker ranks #16 out of 835 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is Bruker's Tariff Resilience Score too high?
Bruker's current Tariff Resilience Score is 7. Based on the distribution chart, Bruker ranks #16 out of 835 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bruker has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bruker's Tariff Resilience Score compare to GKOS and BIO?
According to the Medical Devices & Instruments industry distribution chart, Bruker ranks #16 out of 835 companies for Tariff Resilience Score. This places Bruker in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Bruker's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Based on GuruFocus' analysis, Bruker (FRA:BKD) is currently considered Fairly Valued. The stock's GF Value™ is €54.76, compared to a current price of €52.41 — trading 4.3% below its estimated fair value. The current Tariff Resilience Score is 7. Bruker's overall GF Score™ is 85/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Bruker (FRA:BKD), the current Tariff Resilience Score is 7 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bruker (FRA:BKD) Overvalued in 2026?

Based on GuruFocus' analysis, Bruker stock appears to be undervalued. The current stock price of €52.41 is trading 4.3% below its estimated GF Value™ of €54.76. GuruFocus considers Bruker to be Fairly Valued.

Key valuation signals for FRA:BKD:

  • Tariff Resilience Score: 7
  • GF Value™: €54.76 vs. price of €52.41 (4.3% below fair value)
  • GF Score™: 85/100 with 10 warning signs

No single metric tells the full story. See the FRA:BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bruker Business Description

Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
85GF Score

Get the complete analysis for FRA:BKD

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€52.41
Price
€54.76
GF Value